Specificity of Soluble Phospholipid Binding Sites on Human Factor Xa
Authors:
- 17 May 2002
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 41 (24) , 7751-7762
Abstract
We explore here the specificities of lipid regulatory sites on factor Xa that affect the rate of factor Xa-catalyzed prothrombin activation. We examined a series of 11 phosphatidylserine (PS) analogues in order to map the structural features of a lipid molecule that are needed to elicit both the structural response and the full increase in activity that can be obtained with the PS molecule. Our observations are interpreted in terms of a model in which factor Xa is regulated by sequential occupancy of a pair of linked lipid binding sites, each of which have different minimum ligand structural requirements to induce structural changes. The first site is apparently of higher affinity and recognizes diacylglycerol (DAG) as a minimal binding structure. The second site is occupied with an affinity slightly less than the first site only when the first is occupied, but binds PS with very low affinity otherwise. It recognizes glycerophosphorylserine (GPS) as the minimal ligand. To test this interpretation, experiments were performed in which more than one lipid species was present. It was necessary to invoke the existence of factor Xa species containing different lipids at each site, each having different structural and functional responses. For optimal activity enhancement, both binding sites must be occupied, the first by PS, although the second can be occupied with other lipids.Keywords
This publication has 7 references indexed in Scilit:
- Localization of Phosphatidylserine Binding Sites to Structural Domains of Factor XaJournal of Biological Chemistry, 2002
- Enzymatic synthesis of phosphatidylserine on small scale by use of a one-phase systemJournal of Lipid Research, 1990
- Studies of the role of factor Va in the factor Xa-catalyzed activation of prothrombin, fragment 1.2-prethrombin-2, and dansyl-L-glutamyl-glycyl-L-arginine-meizothrombin in the absence of phospholipid.Journal of Biological Chemistry, 1990
- The active site of blood coagulation factor Xa. Its distance from the phospholipid surface and its conformational sensitivity to components of the prothrombinase complex.Journal of Biological Chemistry, 1987
- Expression of coagulant activity in human platelets: Release of membranous vesicles providing platelet factor 1 and platelet factor 3Thrombosis Research, 1985
- Human coagluation factor V purification and thrombin-catalyzed activation.Journal of Clinical Investigation, 1980
- [12] Factor V1976